Impact of organ preservation using HTK for graft flush and subsequent storage in UW in rat kidney transplantation

European Surgical Research

Volumn 38, Issue 4, 2006, Pages 388-398

  Schmitz, Volker ^a,b   Klawitter, Jost ^a   Bendrick Peart, Jamie ^a   Haschke, Manuel ^a   Beckey, Virginia E ^a   Laudi, Sven ^a   Neumann, Ulf ^b   Schoening, Wenzel ^b   Neuhaus, Peter ^b   Christians, Uwe ^a   Puhl, Gero ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

HTK; Ischemia reperfusion injury; Kidney transplantation; Organ preservation; UW

Indexed keywords

2 OXOGLUTARIC ACID; CREATININE; HISTIDINE; ISOPROSTANE DERIVATIVE; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HIGH ENERGY PHOSPHATE; HISTOLOGY; ISCHEMIA; KIDNEY CONCENTRATING CAPACITY; KIDNEY CORTEX NECROSIS; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; NONHUMAN; ORGAN PRESERVATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SURVIVAL; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION;

ADENOSINE; ALLOPURINOL; ANIMALS; BLOTTING, WESTERN; COLD ISCHEMIA; CREATINE; F2-ISOPROSTANES; GLUCOSE; GLUTATHIONE; IN SITU NICK-END LABELING; INSULIN; KIDNEY; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MANNITOL; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PERFUSION; PHOSPHATES; POTASSIUM CHLORIDE; PROCAINE; RAFFINOSE; RATS; RATS, INBRED LEW;

EID: 33748320886     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094600     Document Type: Article

References (36)

1. Janssen H, Janssen PH, Broelsch CE: Value of energy substrates in HTK and UW to protect human liver endothelial cells against ischemia and reperfusion injury. Eur Surg Res 2004;36:26.
2. Straatsburg IH, Abrahamse SL, Song SW, Hartman RJ, Van Gulik TM: Evaluation of rat liver apoptotic and necrotic cell death after cold storage using UW, HTK, and Celsior. Transplantation 2002;74:458.
3. Bretschneider HJ, Helmchen U, Kehrer G: Kidney protection. Klin Wochenschr 1988;66:817.
4. Morariu AM, Vd Plaats A, V Oeveren W, 'T Hart NA, Leuvenink HG, Graaff R, Ploeg RJ, Rakhorst G: Hyperaggregating effect of hydroxyethyl starch components and University of Wisconsin solution on human red blood cells: a risk of impaired graft perfusion in organ procurement? Transplantation 2003;76:37.
5. de Boer J, Smits JM, De Meester J, et al: A randomized multicenter study on kidney preservation comparing HTK with UW. Transplant Proc 1999;31:2065.
6. Pokorny H, Rasoul-Rockenschaub S, Langer F, et al: Histidine-tryptophan- ketoglutarate solution for organ preservation in human liver transplantation-a prospective multicentre observation study. Transpl Int 2004;17:256.
7. Roels L, Coosemans W, Donck J, et al: Inferior outcome of cadaveric kidneys preserved for more than 24 h in histidine-tryptophan-ketoglutarate solution. Leuven Collaborative Group for Transplantation. Transplantation 1998;66:1660.
8. Southard JH, Beizer FO: Organ preservation. Annu Rev Med 1995;46:235.
9. Shackleton CR, Ettinger SL, McLoughlin MG, Scudamore CH, Miller RR, Keown PA: Effect of recovery from ischemic injury on class I and class II MHC antigen expression. Transplantation 1990;49:641.
10. Canelo R, Hakim NS, Ringe B: Experience with histidine tryptophan ketoglutarate versus University Wisconsin preservation solutions in transplantation. Int Surg 2003;88:145.
11. Pirenne J, Van Gelder F, Coosemans W, et al: Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation. Liver Transpl 2001;7:540.
12. Lombardi D, Gordon KL, Polinsky P, Suga S, Schwartz SM, Johnson RJ: Salt-sensitive hypertension develops after short-term exposure to angiotensin II. Hypertension 1999;33:1013.
13. Serkova N, Jacobsen W, Niemann CU, et al: Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain. Br J Pharmacol 2001;133:875.
14. Samuta T, Becker GL, Pohorecki R, Armstrong K, Landers DF: Effects of isoflurane dose, duration of anoxia, and reoxygenation on isoflurane's preservation of energy balance in anoxic isolated hepatocytes. Anesth Analg 1993;77:38.
15. Hrabalova M, Hrabalova M, Bachleda P, et al: Effect of various protective solutions on function after kidney transplantation. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003;147:197.
16. Steininger R, Roth E, Holzmuller P, et al: Comparison of HTK- and UW-solution for liver preservation tested in an orthotopic liver transplantation model in the pig. Transpl Int 1992;5(suppl 1):S403.
17. Booster MH, van der Vusse GJ, Wijnen RM, Yin M, Stubenitsky BM, Kootstra G: University of Wisconsin solution is superior to histidine tryptophan ketoglutarate for preservation of ischemically damaged kidneys. Transplantation 1994;58:979.
18. Ramella-Virieux SG, Steghens JP, Barbieux A, Zech P, Pozet N, Hadj-Aissa A: Nifedipine improves recovery function of kidneys preserved in a high-sodium, low-potassium cold-storage solution: study with the isolated perfused rat kidney technique. Nephrol Dial Transplant 1997;12:449.
19. Kober IM, Obermayr RP, Brull T, Ehsani N, Schneider B, Spieckermann PG: Comparison of the Solutions of Bretschneider, St. Thomas' Hospital and the National Institutes of Health for cardioplegic protection during moderate hypothermic arrest. Eur Surg Res 1998;30:243.
20. Schnabel PA, Gebhard MM, Pomykaj T, et al: Myocardial protection: left ventricular ultrastructure after different forms of cardiac arrest. Thorac Cardiovasc Surg 1987;35:148.
21. Daemen JH, de Vries B, Oomen AP, DeMeester J, Kootstra G: Effect of machine perfusion preservation on delayed graft function in non-heart-beating donor kidneys: early results. Transpl Int 1997;10:317.
22. Agarwal A, Murdock P, Fridell JA: Comparison of histidine-tryptophan ketoglutarate solution and University of Wisconsin solution in prolonged cold preservation of kidney allografts. Transplantation 2006;81:480.
23. Fuller TF, Freise CE, Serkova N, Niemann CU, Olson JL, Feng S: Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation 2003;76:1594.
24. Nakao A, Neto JS, Kanno S, et al: Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant 2005;5:282.
25. Reutzel-Selke A, Zschockelt T, Denecke C, et al: Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/reperfusion injury and long-term graft function in renal allografts from older donors. Transplantation 2003;75:1786.
26. Serkova N, Fuller TF, Klawitter J, Freise CE, Niemann CU: H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int 2005;67:1142.
27. Yin M, Currin RT, Peng XX, Mekeel HE, Schoonhoven R, Lemasters JJ: Carolina rinse solution minimizes kidney injury and improves graft function and survival after prolonged cold ischemia. Transplantation 2002;73:1410.
28. Belzer FO, Southard JH: Principles of solid-organ preservation by cold storage. Transplantation 1988;45:673.
29. Hauet T, Goujon JM, Vandewalle A: To what extent can limiting cold ischaemia/reperfusion injury prevent delayed graft function? Nephrol Dial Transplant 2001;16:1982.
30. Padanilam BJ: Cell death induced by acute renal injury: A perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol 2003;284:F608.
31. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, Star RA: Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 1997;99:1165.
32. Roberts LJ, Morrow JD: Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000;28:505.
33. Devalaraja-Narashimha K, Singaravelu K, Padanilam BJ: Poly(ADP-ribose) polymerase-mediated cell injury in acute renal failure. Pharmacol Res 2005;52:44.
34. Nicotera P, Leist M, Ferrando-May E: Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol Lett 1998;139:102-103.
35. Virag L, Szabo C: The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002;54:375.
36. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R: In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 1995;21:1465.